janssen science wordmark
UPTRAVI®

(selexipag)

This information is intended for US patients and caregivers to access current scientific information about Janssen products. It is prepared by Janssen Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

UPTRAVI® (selexipag)

Patient Medical Information

+ Save Link

What are the Possible Side Effects of UPTRAVI?

Last Updated: 08/08/2023

IMPORTANT INFORMATION ABOUT UPTRAVI

  • Before you take UPTRAVI, tell your healthcare provider if you have narrowing of the pulmonary veins, a condition called pulmonary veno-occlusive disease.1

summary

What are the possible side effects of UPTRAVI?

  • The most common side effects of UPTRAVI include:1
    • headache
    • jaw pain
    • muscle pain
    • pain in arms or legs
    • pain in joints
    • decreased appetite
    • diarrhea
    • nausea
    • vomiting
    • flushing
    • low red blood cell count
    • rash
    • pain, redness or swelling at the injection site for UPTRAVI for injection
  • These are not all of the possible side effects of UPTRAVI.1
    • Call your doctor for medical advice about side effects. You may report side effects to the Food and Drug Administration (FDA) at 1-800-FDA-1088.

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for UPTRAVI.1

References

Show
1 UPTRAVI (selexipag) [Prescribing Information] Titusville, NJ: Actelion Pharmaceuticals US, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/UPTRAVI-pi.pdf.